ClearPoint Neuro (CLPT) Short Interest Ratio & Short Volume $11.89 -0.35 (-2.86%) (As of 11:55 AM ET) Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends ClearPoint Neuro Short Interest DataClearPoint Neuro (CLPT) has a short interest of 759,900 shares. This marks a 10.51% increase in short interest from the previous month. The short interest ratio (days to cover) is 3.6, indicating that it would take 3.6 days of the average trading volume of 187,216 shares to cover all short positions.Current Short Interest759,900 sharesPrevious Short Interest687,600 sharesChange Vs. Previous Month+10.51%Dollar Volume Sold Short$8.31 millionShort Interest Ratio3.6 Days to CoverLast Record DateNovember 15, 2024Outstanding Shares27,580,000 sharesPercentage of Shares Shorted2.76%Today's Trading Volume27,677 sharesAverage Trading Volume187,216 sharesToday's Volume Vs. Average15% Short Selling ClearPoint Neuro? Sign up to receive the latest short interest report for ClearPoint Neuro and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartCLPT Short Interest Over TimeCLPT Days to Cover Over TimeCLPT Percentage of Float Shorted Over Time Ad Darwin"Start Earning Extra Income with Just $30"What if you could unlock a steady income stream from stocks priced under $30? Our new guide walks you through simple, effective options strategies designed for everyday investors. With step-by-step insights, you’ll learn how to transform familiar names like Ford and Intel into reliable monthly income generators.Claim Your Free Report Now: “Options Made Simple – 2 Affordable Stocks for Monthly Income” ClearPoint Neuro Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 11/15/2024759,900 shares $8.31 million +10.5%N/A3.6 $10.93 10/31/2024687,600 shares $8.52 million -3.5%N/A3.3 $12.39 10/15/2024712,200 shares $8.57 million +15.2%N/A3.6 $12.04 9/30/2024618,500 shares $6.93 million -13.8%N/A3.4 $11.21 9/15/2024717,800 shares $9.04 million +1.2%N/A2.9 $12.59 8/31/2024709,400 shares $9.21 million -11.3%N/A3 $12.98 Get the Latest News and Ratings for CLPT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for ClearPoint Neuro and its competitors with MarketBeat's FREE daily newsletter. 8/15/2024799,700 shares $8.67 million -0.7%N/A3.4 $10.84 7/31/2024805,400 shares $5.77 million -5.9%N/A3.6 $7.16 7/15/2024855,900 shares $6.44 million -37.5%N/A4.1 $7.52 6/30/20241,370,000 shares $7.38 million +9.6%N/A6.7 $5.39 6/15/20241,250,000 shares $6.76 million +4.2%N/A9.1 $5.41 5/31/20241,200,000 shares $6.52 million -6.3%N/A8.3 $5.43 5/15/20241,280,000 shares $8.19 million -5.9%N/A7.8 $6.40 4/30/20241,360,000 shares $7.38 million +10.6%N/A8.7 $5.43 4/15/20241,230,000 shares $6.90 million -3.9%N/A8.2 $5.61 3/31/20241,280,000 shares $8.70 million -8.6%N/A8.4 $6.80 3/15/20241,400,000 shares $10.01 million +0.7%N/A9 $7.15 2/29/20241,390,000 shares $8.88 million -2.8%N/A10.3 $6.39 2/15/20241,430,000 shares $10.65 million +3.6%N/A14.4 $7.45 1/31/20241,380,000 shares $9.60 million +3.8%N/A13.1 $6.96 1/15/20241,330,000 shares $9.54 million No ChangeN/A12.5 $7.17 12/31/20231,330,000 shares $9.03 million -8.3%N/A13.2 $6.79 12/15/20231,450,000 shares $9.03 million -0.7%N/A15.3 $6.23 11/30/20231,460,000 shares $8.41 million +0.7%N/A15.7 $5.76 11/15/20231,450,000 shares $7.16 million +0.7%N/A15.7 $4.94 10/31/20231,440,000 shares $7.92 million No ChangeN/A15.8 $5.50 10/15/20231,440,000 shares $6.67 million +13.4%N/A14.2 $4.63 9/30/20231,270,000 shares $6.36 million -1.6%N/A12.9 $5.01 9/15/20231,290,000 shares $6.63 million +3.2%N/A12.8 $5.14 8/31/20231,250,000 shares $7.26 million +10.6%N/A7.9 $5.81 8/15/20231,130,000 shares $6.78 million No ChangeN/A6 $6.00 7/31/20231,130,000 shares $7.76 million -4.2%N/A6.3 $6.87 7/15/20231,180,000 shares $7.76 million +6.3%N/A7 $6.58 6/30/20231,110,000 shares $8.04 million +53.9%N/A6.5 $7.24 6/15/2023721,100 shares $5.02 million +0.6%N/A4.3 $6.96 5/31/2023716,700 shares $5.52 million -1.8%N/A6.8 $7.70 5/15/2023729,700 shares $6.54 million +2.5%N/A9.7 $8.96 4/30/2023712,200 shares $7.49 million -6.4%N/A10.1 $10.52 4/15/2023760,700 shares $8.04 million +1.1%N/A10.3 $10.57 3/31/2023752,600 shares $6.35 million +6.6%N/A10.6 $8.44"Start Earning Extra Income with Just $30" (Ad)What if you could unlock a steady income stream from stocks priced under $30? Our new guide walks you through simple, effective options strategies designed for everyday investors. With step-by-step insights, you’ll learn how to transform familiar names like Ford and Intel into reliable monthly income generators.Claim Your Free Report Now: “Options Made Simple – 2 Affordable Stocks for Monthly Income” 3/15/2023706,000 shares $5.37 million -2.1%N/A9.9 $7.61 2/28/2023720,900 shares $6.11 million +0.5%N/A10.3 $8.48 2/15/2023717,000 shares $6.52 million -2.2%N/A10.3 $9.10 1/31/2023733,200 shares $6.97 million -5.7%N/A9.6 $9.51 1/15/2023777,600 shares $8.27 million -1.3%N/A9.9 $10.63 12/30/2022788,100 shares $6.68 million -1.3%N/A9.5 $8.47 12/15/2022798,600 shares $6.57 million +1.1%N/A9.3 $8.23 11/30/2022790,100 shares $7.45 million -3.3%N/A8.6 $9.43 11/15/2022816,700 shares $8.26 million -2.0%N/A8.6 $10.11 10/31/2022833,200 shares $8.34 million -3.4%N/A7.5 $10.01 10/15/2022862,300 shares $8.31 million -6.0%N/A7.4 $9.64 9/30/2022917,100 shares $9.50 million -1.9%N/A7.7 $10.36 9/15/2022934,400 shares $11.07 million +0.5%N/A5.5 $11.85 8/31/2022930,200 shares $11.97 million -12.3%N/A5.3 $12.87 8/15/20221,060,000 shares $16.98 million -15.2%N/A5.5 $16.02 7/31/20221,250,000 shares $17.71 million -3.1%6.6%6 $14.17 7/15/20221,290,000 shares $16.43 million -3.7%7.0%5.8 $12.74 6/30/20221,340,000 shares $17.49 million -28.0%7.2%5.7 $13.05 6/15/20221,860,000 shares $19.21 million +2.2%10.0%8 $10.33 5/31/20221,820,000 shares $19.95 million +0.6%9.8%9.2 $10.96 5/15/20221,810,000 shares $15.48 million +24.8%9.7%8.6 $8.55 4/30/20221,450,000 shares $12.43 million +2.8%7.8%7.2 $8.57 4/15/20221,410,000 shares $16.07 million +3.7%7.6%6.3 $11.40 3/31/20221,360,000 shares $14.16 million No Change7.3%6 $10.41 3/15/20221,360,000 shares $10.93 million +3.0%7.3%5.7 $8.04 2/28/20221,320,000 shares $11.55 million +20.0%7.1%5.1 $8.75 2/15/20221,100,000 shares $9.19 million +14.6%5.9%4.1 $8.35 1/31/2022959,600 shares $8.47 million +21.9%5.2%3.3 $8.83 1/15/2022787,400 shares $7.76 million +8.9%N/A2.8 $9.85 12/31/2021723,000 shares $8.11 million -7.4%3.8%2.7 $11.22 12/15/2021780,400 shares $9.08 million +18.4%4.1%3.1 $11.64 11/30/2021659,300 shares $9.05 million +1.0%3.5%2.9 $13.73 11/15/2021653,000 shares $10.39 million -15.1%3.5%3 $15.91 10/29/2021769,300 shares $12.87 million -4.2%4.4%3.5 $16.73 10/15/2021803,000 shares $14.42 million -6.6%4.6%3.4 $17.96 9/30/2021859,600 shares $15.26 million -6.6%4.9%3.3 $17.75 9/15/2021920,600 shares $16.55 million +7.4%5.2%2.7 $17.98 8/31/2021857,400 shares $16.18 million -38.8%5.0%2.4 $18.87 8/13/20211,400,000 shares $24.78 million +10.2%8.1%3.6 $17.70 7/30/20211,270,000 shares $28.23 million +11.4%7.9%3.4 $22.23 7/15/20211,140,000 shares $19.07 million +38.2%7.1%3.2 $16.73 6/30/2021825,000 shares $15.75 million +70.4%5.1%2.2 $19.09 6/15/2021484,100 shares $9.35 million -13.0%3.0%1.4 $19.32 5/28/2021556,200 shares $10.25 million +13.6%3.3%1.5 $18.42 5/14/2021489,600 shares $8.54 million -5.6%2.9%1.1 $17.45 4/30/2021518,400 shares $10.99 million +28.8%3.1%1.1 $21.20 4/15/2021402,600 shares $8.37 million +23.9%2.4%0.8 $20.80 3/31/2021324,900 shares $6.36 million +3.6%2.0%0.7 $19.58 3/15/2021313,600 shares $6.35 million +63.0%1.9%0.7 $20.25 2/26/2021192,400 shares $4.16 million -2.9%1.2%0.5 $21.64"Start Earning Extra Income with Just $30" (Ad)What if you could unlock a steady income stream from stocks priced under $30? Our new guide walks you through simple, effective options strategies designed for everyday investors. With step-by-step insights, you’ll learn how to transform familiar names like Ford and Intel into reliable monthly income generators.Claim Your Free Report Now: “Options Made Simple – 2 Affordable Stocks for Monthly Income” 2/12/2021198,100 shares $5.04 million -45.1%1.4%0.6 $25.44 1/29/2021360,800 shares $8.76 million +31.3%2.8%1.5 $24.27 1/15/2021274,800 shares $4.33 million No Change2.1%1.2 $15.76 CLPT Short Interest - Frequently Asked Questions What is ClearPoint Neuro's current short interest? Short interest is the volume of ClearPoint Neuro shares that have been sold short but have not yet been covered or closed out. As of November 15th, traders have sold 759,900 shares of CLPT short. Learn More on ClearPoint Neuro's current short interest. What is a good short interest ratio for ClearPoint Neuro? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. CLPT shares currently have a short interest ratio of 4.0. Learn More on ClearPoint Neuro's short interest ratio. Is ClearPoint Neuro's short interest increasing or decreasing? ClearPoint Neuro saw a increase in short interest in November. As of November 15th, there was short interest totaling 759,900 shares, an increase of 10.5% from the previous total of 687,600 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does ClearPoint Neuro's short interest compare to its competitors? Here is how the short interest of companies in the industry of "medical equipment" compare to ClearPoint Neuro: Establishment Labs Holdings Inc. (21.48%), Pulse Biosciences, Inc. (12.16%), BioLife Solutions, Inc. (5.78%), Artivion, Inc. (8.18%), Embecta Corp. (2.40%), Liquidia Co. (12.12%), Avanos Medical, Inc. (1.23%), National Vision Holdings, Inc. (5.89%), Paragon 28, Inc. (11.66%), Butterfly Network, Inc. (8.45%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($4.85 billion), Charter Communications, Inc. ($4.81 billion), International Paper ($2.96 billion), Cencora, Inc. ($2.40 billion), Paychex, Inc. ($2.38 billion), Lululemon Athletica Inc. ($2.05 billion), SoFi Technologies, Inc. ($2.03 billion), Live Nation Entertainment, Inc. ($1.93 billion), Onsemi ($1.82 billion), and Tractor Supply ($1.65 billion). View all of the most shorted stocks. What does it mean to sell short ClearPoint Neuro stock? Short selling CLPT is an investing strategy that aims to generate trading profit from ClearPoint Neuro as its price is falling. CLPT shares are trading down $0.13 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against ClearPoint Neuro? A short squeeze for ClearPoint Neuro occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of CLPT, which in turn drives the price of the stock up even further. How often is ClearPoint Neuro's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CLPT, twice per month. The most recent reporting period available is November, 15 2024. More Short Interest Resources from MarketBeat Related Companies Establishment Labs Short Squeeze Pulse Biosciences Short Squeeze BioLife Solutions Short Squeeze Artivion Short Squeeze Embecta Short Squeeze Liquidia Short Squeeze Avanos Medical Short Squeeze National Vision Short Squeeze Paragon 28 Short Squeeze Butterfly Network Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:CLPT) was last updated on 12/3/2024 by MarketBeat.com Staff From Our PartnersTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredYour bank is lying to you.You might think you have your money in a high-yield savings account, but do you really? The national average A...MyBankTracker | SponsoredHow this >10-cent coin is going to outperform Bitcoin Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredIs NVDA a sell? Buy this stock instead before Dec 3After months of speculation that Nvidia was "cooling off..." and "running out of steam..." The company is m...Chaikin Analytics | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ClearPoint Neuro, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share ClearPoint Neuro With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
